Example: Heart Attack

Search clinical trials for: MET-2

Total 9 results

NCT04602715

Recruiting

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression

Conditions: Major Depressive Disorder, Anxiety
NCT03832400

Completed

Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)

Conditions: Ulcerative Colitis
NCT02865616

Completed

MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)

Conditions: Clostridium Difficile Infection
NCT03660748

Completed

Safety and Efficacy of MET-3 in Obese Human Subjects

Conditions: Obesity
NCT04052451

Completed

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder

Conditions: Depression, Anxiety
NCT02073227

Completed

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

Conditions: Healthy Volunteers
NCT02077803

Completed

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants

Conditions: Healthy
NCT02071368

Completed

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants

Conditions: Healthy
NCT02065752

Completed

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

Conditions: Healthy Volunteers

Search clinical trials for: MET-2

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations